ASARFI HOSPITAL LIMITED

BSE: ASARFI543943ISIN INE0DN001027

Healthcare
Hospital

Share price

₹176.40+8.95 (+5.34%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹256.95
52W low: ₹135.00
Off 52W high: -31.35%
1M return: -5.14%
3M return: -14.16%
6M return: -28.26%
1Y return: +22.97%
20D avg volume: 35,750
50 DMA: ₹187.10
200 DMA: ₹195.76

Key ratios Consolidated

Market cap: ₹347.11 Cr
Current price: ₹176.40
52W high / low: ₹256.95 / ₹135.00
Face value: ₹10.00
P/E: —
P/B: —
EPS (TTM): —
Book value / share: —
ROE: —
ROCE: 18.40%
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: 6.23
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 85.8 days

Financials

Metric	FY26	FY25	FY24
Income statement
	173.50	120.57	84.40
	2.70	7.52	1.67
	176.21	128.09	86.07
	154.01	113.78	79.83
	26.75	19.40	16.21
	12.91	9.09	4.31
	26.47	18.63	14.13
	4.24	4.08	2.69
	—	12.68	8.79
	72.95	50.53	33.90
	22.19	14.31	6.24
	0.00	0.00	0.00
	22.19	14.31	6.24
	5.53	3.73	2.08
	16.66	10.58	4.16
	8.47	5.37	—
Key metrics
	26.43	31.07	17.72
	15.20%	25.80%	21.00%
	9.60%	8.80%	4.90%
	18.40%	15.00%	—
	43.90%	42.90%	—
	57.50%	154.30%	—
	0.19	-16.14	—
	1.10	-0.41	—
	85.8	87.9	—
Balance sheet
	193.16	163.89	—
	71.40	58.48	—
	6.22	1.43	—
	54.12	39.80	—
	3.22	2.28	—
	0.30	14.11	—
	108.23	101.64	—
	16.57	13.04	—
	49.15	41.04	—
Cash flow
	18.30	-4.35	—
	-18.29	-7.38	—
	4.76	12.57	—
	18.11	11.79	—

Metric	Q4 FY26	Q2 FY26	Q4 FY25	Q4 FY24
Income statement
	—	—	—	44.08
	—	—	—	0.79
	—	—	—	44.87
	—	—	—	41.84
	—	—	—	8.68
	—	—	—	2.28
	—	—	—	7.66
	—	—	—	1.36
	—	—	—	4.39
	—	—	—	17.64
	—	—	—	3.04
	—	—	—	3.04
	—	—	—	0.90
	—	—	—	2.14
	—	—	—	0.60
Key metrics
	—	—	—	8.79
	—	—	—	19.90%
	—	—	—	4.90%

Metric	FY26	FY25	FY24
Income statement
	173.20	120.57	84.40
	2.79	7.57	1.67
	175.98	128.13	86.07
	153.37	113.42	79.78
	26.75	19.40	16.21
	12.91	9.09	4.31
	26.21	18.61	14.13
	4.24	4.08	2.69
	11.44	12.62	8.78
	72.67	50.25	33.85
	22.61	14.71	6.29
	22.61	14.71	6.29
	5.53	3.73	2.08
	23.31	10.98	4.21
	8.68	5.58	2.33
Key metrics
	38.29	31.41	17.76
	22.10%	26.10%	21.00%
	13.50%	9.10%	5.00%
	18.50%	15.20%	—
	43.70%	42.90%	—
	112.30%	160.80%	—
	1.00	-15.47	—
	0.82	-0.35	—
	85.8	88.0	—
Balance sheet
	193.89	164.31	—
	71.06	58.37	—
	6.10	1.32	—
	54.07	39.80	—
	3.22	2.28	—
	0.30	14.11	—
	108.14	101.48	—
	16.56	13.03	—
	49.01	41.00	—
Cash flow
	19.09	-3.84	—
	-19.09	-7.90	—
	4.76	12.57	—
	18.09	11.63	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 61.19%

Holder	Type	Holding	Previous	Change
HARENDRA SINGH	Promoter	18.78%	—	—
NAYAN PRAKASH SINGH	Promoter	17.74%	—	—
UDAI PRATAP SINGH	Promoter	11.96%	—	—
MADHURI SINGH	Promoter	4.02%	—	—
ASAP IMPACT PRIVATE LIMITED	Promoter Group	3.33%	—	—
NITU SINGH	Promoter	2.89%	—	—
GOPAL SINGH	Public	2.40%	—	—
SUKANTI KUMAR DAS	Public	1.68%	—	—
INDIA-AHEAD VENTURE FUND	Public	1.50%	—	—
RAJIV RANJAN SINGH	Promoter Group	1.20%	—	—
SAROJ SINGH	Public	1.03%	—	—
INDU JAIN	Public	1.02%	—	—
RITESH KUMAR SINGH	Promoter Group	0.35%	—	—
MAHESH SINGH	Promoter Group	0.34%	—	—
ASARFI DEVI	Promoter Group	0.30%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

We wish to inform you that CRISIL RATINGS LIMITED has upgraded the credit Rating of the Bank Facilities of Asarfi Hospital Limited.8 Oct 2026 · Company Update / Credit Rating
We hereby inform you that the Trading Window for dealing in the securities of the company shall remain closed for all designated persons and their Immediate Relatives with effected from ....27 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
we hereby submitted consolidated voting results on the business transacted at the 21st AGM of the company held on Friday, September 18, 2026 in the prescribed format along with the consolidated ....22 Sep 2026 · AGM/EGM / Postal Ballot
Summary Proceedings of 21ST Annual General Meeting of the Company held on Friday, 18th September''2026 Pursuant to Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) ....18 Sep 2026 · AGM/EGM / AGM
We hereby submit the Annual Report of Asarfi Hospital Limited for the Financial Year 2025-26, including the Notice convening the Annual General Meeting.5 Sep 2026 · Others / Reg. 34 (1) Annual Report
We hereby inform you that the board of Director of the company at their meeting held on August 25, 2026 pursuant to the recommendation of the Audit Committee has approved the Appointment ....5 Sep 2026 · Company Update / General
We hereby inform you that the meeting of the Board of Directors of Asarfi Hospital Limited was held on Tuesday, August 25, 2026 at 11:00 A.M. at the registered office of the Company at ....25 Aug 2026 · Board Meeting / Outcome of Board Meeting
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2026 ,inter alia, to consider and approve Notice is hereby given that ....18 Aug 2026 · Board Meeting / Board Meeting
Submission of Newspaper Advertisement of unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026.8 Aug 2026 · Company Update / Press Release / Media Release
Intimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015- Submission of Press Release/ Media Release.7 Aug 2026 · Company Update / Press Release / Media Release
We hereby submit the Investor Presentation for the Qtr ended 30th June 2026.7 Aug 2026 · Company Update / Investor Presentation
We wish to inform you that the board of Director of Asarfi Hospital Limited at its meeting held today, i.e, 07 August 2026, has considered and approved the unaudited standalone and consolidated ....7 Aug 2026 · Result / Financial Results
We wish to inform you that the Board of Directors of Asarfi Hospital Limited ("the Company"), at its meeting held today, i.e., 07 August 2026, has considered and approved the Unaudited ....7 Aug 2026 · Board Meeting / Outcome of Board Meeting
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve of the Unaudited Financial ....4 Aug 2026 · Board Meeting / Board Meeting
We wish you to inform you that the management of Asarfi Hospital Limited Participated in Analyst/ Investor Webinar held on 24th July'' 2026 from 04:30 PM to 5:30 PM (IST).27 Jul 2026 · Company Update / General
we wish to inform you that the Company will participate in an Analyst/Institutional Investor Meeting on dated July 24, 2026.16 Jul 2026 · Company Update / Analyst / Investor Meet
We hereby inform you that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated persons and their Immediate Relative from July''01, 2026. ....30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Saturday, 27 June 2026, commenced at 3:00 P.M. and concluded at 7:30 P.M., inter alia, considered ....27 Jun 2026 · Others / Outcome without intimation
We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating ....30 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ....30 May 2026 · Company Update / Earnings Call Transcript
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our intimation dated May 21, 2026 regarding the schedule ....27 May 2026 · Company Update / Analyst / Investor Meet
With reference to our earlier intimation regarding the Analyst / Investor Meeting scheduled to be held on Monday, May 25, 2026, at 04:00 P.M. (IST), we wish to inform you that due to unavoidable ....21 May 2026 · Company Update / Analyst / Investor Meet
We wish to inform you that the Company has scheduled a Conference Call with Analysts / Investors on Monday, May 25, 2026 at 04:00 P.M. (IST), inter alia, to discuss the Audited Financial ....20 May 2026 · Company Update / Analyst / Investor Meet
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.12 May 2026 · Company Update / Press Release / Media Release
We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.12 May 2026 · Company Update / Press Release / Media Release
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulation 15 - Press Release Titled Extract of Audited Standalone and Consolidated Financial Results ....11 May 2026 · Company Update / Press Release / Media Release
Investor Presentation of Asarfi Hospital Limited for the Quarter and Financial Year ended 31st March, 2026.11 May 2026 · Company Update / Investor Presentation
We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e, Monday 11th May 2026, has inter alia considered and approved the standalone and ....11 May 2026 · Result / Financial Results
We wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i.e. Monday, 11th May, 2026, has inter alia considered and approved the Audited Standalone ....11 May 2026 · Board Meeting / Outcome of Board Meeting
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Pursuant to the aforesaid regulation, ....4 May 2026 · Board Meeting / Board Meeting
In term of the provision of the securities and Exchange Board of India (PIT) Regulation,2015 as amended from to time and Prohibition of Insider trading policy ("the Policy").The Trading ....27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of Press Release/Media Release Under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulation, 2015.10 Feb 2026 · Company Update / Press Release / Media Release
With Reference the captioned subject, Press Release / Media Release title Extract of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31,2025.9 Feb 2026 · Company Update / Press Release / Media Release
We Submission the Investor Presentation of the Company for the quarter ended December 31,2025.9 Feb 2026 · Company Update / Investor Presentation
We wish to inform you that the Board of Director of Asarfi Hospital Limited at its meeting held today i.e., 09-February''26 has considered and approved the unaudited standalone and consolidated ....9 Feb 2026 · Result / Financial Results
We wish to inform you that the Board of Directors of Asarfi Hospital Limited ('the Company'), at its meeting held today i.e. 09 February, 2026, has considered and approved the Unaudited ....9 Feb 2026 · Board Meeting / Outcome of Board Meeting
Asarfi Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Notice is hereby given that ....2 Feb 2026 · Board Meeting / Board Meeting
Intimation for closure of Trading Window under security and exchange board of India (PIT) Regulation 2015.27 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
We hereby inform you that the management of the company met with group of investor held by the Hem Securities Samrudhi 2025- Virtual SME Conclave through virtual mode on Thursday, December 4,2025.5 Dec 2025 · Company Update / General
This is to inform you that the Company will be meeting Investors/Analysts on dated November 04, 2025 organized by Hem Securities - Samrudhi 2025 Virtual SME Conclave.2 Dec 2025 · Company Update / Analyst / Investor Meet

Board meetings

7 Aug 2026 Board Meeting - Financial Results